A Qualitative Study of Client-Clinician Text Exchanges in a Mobile Health Intervention for Individuals With Psychotic Disorders and Substance Use

Journal of Dual Diagnosis
Kelly AschbrennerDror Ben-Zeev

Abstract

Mobile health (mHealth) approaches have the potential to transform prevention, wellness, and illness management for people with dual diagnosis consisting of co-occurring mental illness and substance use disorders by providing timely and cost-effective interventions in clients' natural environments. However, little is known about how clients interact with mHealth interventions to manage their illness. This qualitative study explored the content of mobile phone text messages between clients with dual diagnosis and a clinician who engaged them in daily assessment and intervention text exchanges. Seventeen participants with psychotic disorders and substance use were enrolled in a 12-week single-arm trial of an mHealth intervention focusing on illness management. The clinician (i.e., mobile interventionist) sent daily text messages to participants' privately owned mobile phones to assess their medication adherence and clinical status. The clinician provided other illness management and wellness suggestions flexibly, in response to participants' needs and preferences. In this qualitative study we conducted a thematic analysis of the client-clinician text exchanges that occurred over the course of the intervention. Seven major content...Continue Reading

References

May 30, 2006·Chronic Respiratory Disease·Suzanne C Lareau
Aug 11, 2006·Schizophrenia Bulletin·Kim T MueserMichelle P Salyers
Jan 13, 2009·American Journal of Preventive Medicine·Brianna S FjeldsoeYvette D Miller
Jun 6, 2009·Schizophrenia Bulletin·Robert E DrakeSusan M Essock
Jun 1, 2012·Administration and Policy in Mental Health·Dror Ben-ZeevRobert E Drake
Aug 7, 2012·Current Psychiatry Reports·María Montserrat Sánchez-Ortuño, Jack D Edinger
Feb 21, 2013·PLoS Medicine·Mark TomlinsonAlexander C Tsai
Mar 23, 2013·The New England Journal of Medicine·Gail L DaumitLawrence J Appel
May 17, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Stephen J BartelsKim T Mueser
Jun 5, 2013·Social Work in Public Health·Kim T Mueser, Susan Gingerich
Dec 10, 2013·Annual Review of Clinical Psychology·Thomas Munk LaursenPreben Bo Mortensen
Mar 7, 2014·Worldviews on Evidence-based Nursing·Katherine R JonesNapatsawan Kaewluang
Sep 16, 2014·The American Journal of Psychiatry·Carla A GreenVictor J Stevens
Nov 14, 2014·Journal of Dual Diagnosis·Robert E Drake, Alan I Green
Nov 14, 2014·Journal of Dual Diagnosis·Dror Ben-Zeev
Dec 3, 2014·Sleep Medicine Reviews·Leah A IrishMartica H Hall
Feb 12, 2015·JAMA Psychiatry·Elizabeth Reisinger WalkerBenjamin G Druss
Feb 24, 2015·BMJ : British Medical Journal·Dror Ben-ZeevLisa Marsch
Mar 18, 2015·Journal of Dual Diagnosis·Robert E Drake, Alan I Green
May 29, 2015·Acta Psychiatrica Scandinavica·P ManuC U Correll
May 29, 2015·Journal of Mental Health·John A NaslundStephen J Bartels
Jun 30, 2015·Annals of Internal Medicine·Ryan A CrowleyUNKNOWN Health and Public Policy Committee of the American College of Physicians

❮ Previous
Next ❯

Citations

Feb 2, 2016·Journal of Dual Diagnosis·Robert E Drake, Alan I Green
Feb 15, 2019·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Elizabeth May CarrZarrin Seema Siddiqui
Nov 25, 2018·Journal of Medical Internet Research·Amia EnamHenrik Eriksson
Sep 14, 2019·Nursing Forum·Cassandra M Godzik
Mar 2, 2018·General Hospital Psychiatry·Amritha BhatJennifer Unger

❮ Previous
Next ❯

Methods Mentioned

BETA
chips

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here